Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Estrella Immunopharma, Inc.
Market Cap
$18.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.82M
Operating Margin
-24.65%
TTM Avg
-26.95%
3Y Avg
-27.41%
5Y Avg
-18.80%
Market Cap
$20.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$16.58M
Operating Margin
-116.95%
TTM Avg
-227.41%
3Y Avg
-381.13%
5Y Avg
-401.11%
Market Cap
$16.54M
Operating Margin
-579.88%
TTM Avg
-374.35%
3Y Avg
-344.88%
5Y Avg
-436.34%
Market Cap
$16.22M
Operating Margin
0.00%
TTM Avg
-6897.41%
3Y Avg
-4279.04%
5Y Avg
-4845.03%
Market Cap
$15.91M
Operating Margin
-3939.06%
TTM Avg
-1969.53%
3Y Avg
-984.76%
5Y Avg
-656.51%
Market Cap
$21.90M
Operating Margin
-14.44%
TTM Avg
-13.11%
3Y Avg
-11.14%
5Y Avg
-41.32%
Market Cap
$15.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-79.33%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $18.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -24.65% | -26.95% | -27.41% | -18.80% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -116.95% | -227.41% | -381.13% | -401.11% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -579.88% | -374.35% | -344.88% | -436.34% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 0.00% | -6897.41% | -4279.04% | -4845.03% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -3939.06% | -1969.53% | -984.76% | -656.51% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -14.44% | -13.11% | -11.14% | -41.32% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 0.00% | 0.00% | 0.00% | -79.33% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | 0.00% | 0.00% | 0.00% | -4987.62% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-02-28 | 0.00% |
